Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics

Experimental Hematology

Volumn 35, Issue 6, 2007, Pages 861-871

  Yakoub Agha, Ibrahim ^a   Saule, Pasquine ^b   Depil, Stephane ^a   Grutzmacher, Claudine ^b   Boulanger, Florence ^c   Magro, Leonardo ^a   Jouet, Jean Pierre ^a   Dessaint, Jean Paul ^b   Labalette, Myriam ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGRAFT; ARTICLE; BLOOD DONOR; BONE MARROW CELL; CD4 CD8 RATIO; CELL POPULATION; COMPARATIVE ANATOMY; CONTROLLED STUDY; CYTOMEGALOVIRUS; GROUPS BY AGE; HUMAN; HUMAN CELL; INFECTION; MEMORY CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXOPLASMOSIS;

ACUTE DISEASE; ADULT; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DONOR SELECTION; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOLOGIC MEMORY; LIVING DONORS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEPTORS, CHEMOKINE; TRANSPLANTATION, HOMOLOGOUS;

CYTOMEGALOVIRUS;

EID: 34249092985     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.03.006     Document Type: Article

References (68)

1. Barrett A.J., Rezvani K., Solomon S., et al. New developments in allotransplant immunology. Hematology (Am Soc Hematol Educ Program) (2003) 350-371
2. + T cells by virtue of their receptor beta loci sequences. Proc Natl Acad Sci U S A 100 (2003) 1180-1184
3. Ringden O., Labopin M., Gorin N.C., et al. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?. Br J Haematol 111 (2000) 1130-1137
4. Wu C.J., and Ritz J. Induction of tumor immunity following allogeneic stem cell transplantation. Adv Immunol 90 (2006) 133-173
5. Guardiola P., Runde V., Bacigalupo A., et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 99 (2002) 4370-4378
6. Robinet E., Lapierre V., Tayebi H., et al. Blood versus marrow hematopoietic allogeneic graft. Transfus Apheresis Sci 29 (2003) 53-59
7. Kernan N.A., Collins N.H., Juliano L., et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 68 (1986) 770-773
8. + selected cells from peripheral blood from HLA-identical siblings. Blood 97 (2001) 383-387
9. + T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 20 (2006) 1557-1565
10. Suchin E.J., Langmuir P.B., Palmer E., et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166 (2001) 973-981
11. Adams A.B., Williams M.A., Jones T.R., et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111 (2003) 1887-1895
12. + cytotoxic T lymphocytes: implications for graft-versus-host disease. Blood 105 (2005) 1362-1364
13. Landais E., Morice A., Long H.M., et al. EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses. J Immunol 177 (2006) 1427-1433
14. Reichstetter S., Standifer N.E., Geubtner K.A., et al. Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601. Immunology 117 (2006) 350-357
15. Beilhack A., Schulz S., Baker J., et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106 (2005) 1113-1122
16. Ferrara J.L., and Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 43 (2006) 3-10
17. Wysocki C.A., Panoskaltsis-Mortari A., Blazar B.R., and Serody J.S. Leukocyte migration and graft-versus-host disease. Blood 105 (2005) 4191-4199
18. Sallusto F., Lenig D., Forster R., et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712
19. Anderson B.E., McNiff J., Yan J., et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 112 (2003) 101-108
20. Bondanza A., Valtolina V., Magnani Z., et al. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107 (2006) 1828-1836
21. - memory T cells without graft-versus-host disease. Blood 103 (2004) 1534-1541
22. Li B., New J.Y., Yap E.H., Lu J., Chan S.H., and Hu H. Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur J Immunol 31 (2001) 617-624
23. + naïve T cells: potential for adoptive immunotherapy and allodepletion. Blood 104 (2004) 2403-2409
24. + compartment. Mech Ageing Dev 127 (2006) 274-281
25. + T cells are predominantly distributed among six phenotypically and functionally distinct subsets. J Immunol 175 (2005) 5765-5773
26. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8 (2002) 379-385
27. + central and effector memory T cell subsets are largely distinct. Immunity 18 (2003) 193-204
28. Harari A., Vallelian F., and Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol 34 (2004) 3525-3533
29. +, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 173 (2004) 1834-1841
30. + T-cell differentiation in response to viruses. Nat Rev Immunol 3 (2003) 931-939
31. + CTLs ex vivo. J Immunol 168 (2002) 5954-5958
32. + T subsets with distinct replicative history and partial effector functions. Blood 102 (2003) 1779-1787
33. + T cells differently expressing three cytolytic effector molecules. J Immunol 177 (2006) 4330-4340
34. Monteiro M., Evaristo C., Legrand A., Nicoletti A., and Rocha B. Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression. Blood (2006) Dec 5; [Epub ahead of print]
35. Martins S.L., St John L.S., Champlin R.E., et al. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. Blood 104 (2004) 3429-3436
36. Yu X.Z., Albert M.H., and Anasetti C. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells. J Immunol 176 (2006) 3383-3380
37. Ottinger H.D., Beelen D.W., Scheulen B., Schaefer U.W., and Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 (1996) 2775-2779
38. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
39. Tayebi H., Kuttler F., Saas P., et al. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 29 (2001) 458-470
40. Appay V., Reynard S., Voelter V., Romero P., Speiser D.E., and Leyvraz S. Immuno-monitoring of CD8 + T cells in whole blood versus PBMC samples. J Immunol Methods 309 (2006) 192-199
41. Sallusto F., and Geginat J. Lanzavecchia A Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22 (2004) 745-763
42. Blaise D., Kuentz M., Fortanier C., et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol 18 (2000) 537-546
43. Redoglia V., Boccadoro M., Battaglio S., Dianzani U., Massaia M., and Pileri A. Multiple myeloma: altered CD4/CD8 ratio in bone marrow. Haematologica 75 (1990) 129-131
44. Clark P., and Normansell D.E. Phenotype analysis of lymphocyte subsets in normal human bone marrow. Am J Clin Pathol 94 (1990) 632-636
45. Shier L.R., Schultz K.R., Imren S., et al. Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors. Biol Blood Marrow Transplant 10 (2004) 624-634
46. Rondelli D., Raspadori D., Anasetti C., et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant 22 (1998) 631-637
47. - T cells. Bone Marrow Transplant 23 (1999) 119-124
48. Tayebi H., Tiberghien P., Ferrand C., et al. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation. Bone Marrow Transplant 27 (2001) 167-175
49. Franzke A., Piao W., Lauber J., et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102 (2003) 734-739
50. Jun H.X., Jun C.Y., and Yu Z.X. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 89 (2004) 1517-1524
51. Rutella S., Pierelli L., Bonanno G., et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cellls. Blood 100 (2002) 2562-2571
52. Rutella S., Zavala F., Danese S., Kared H., and Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 175 (2005) 7085-7091
53. Condomines M., Quittet P., Lu Z.Y., et al. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J Immunol 176 (2006) 6631-6639
54. Di Rosa F., and Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol 26 (2005) 360-366
55. Feuerer M., Beckhove P., Garbi N., et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med 9 (2003) 1151-1157
56. + T cells. Immunity 22 (2005) 259-270
57. Zhang X., Dong H., Lin W., et al. Human bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function. J Immunol 177 (2006) 6730-6767
58. Beckhove P., Feuerer M., Dolenc M., et al. Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors. J Clin Invest 114 (2004) 67-76
59. - progeny, but IL-4 prevents loss of CD28 expression. Int Immunol 11 (1999) 1327-1136
60. + T cells. J Immunol 175 (2005) 755-762
61. Flowers M.E., Pepe M.S., Longton G., et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol 74 (1990) 492-496
62. Adams K.M., Holmberg L.A., Leisenring W., et al. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood 104 (2004) 1894-1897
63. Purner M.B., Berens R.L., Nash P.B., et al. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect Immun 64 (1996) 4330-4338
64. + T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175 (2005) 8218-8225
65. + T-cell subsets in the elderly. Hum Immunol 68 (2007) 86-90
66. + memory T cells reveals early branched pathways of T cell differentiation in humans. Proc Natl Acad Sci U S A 102 (2005) 7916-7921
67. Boland G.J., Vlieger A.M., Ververs C., and De Gast G.C. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation. Clin Exp Immunol 88 (1992) 506-511
68. Ljungman P., Brand R., Einsele H., et al. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood 102 (2003) 4255-4260